Groups
Researchers
Results
Atanasio
Pandiella Alonso
Instituto Valenciano de Oncologia
Valencia, España
You are in
Collaborations
Instituto Valenciano de Oncologia
Publications in collaboration with researchers from Instituto Valenciano de Oncologia (1)
2017
A phase I study of the SRC kinase inhibitor dasatinib with trastuzumab and paclitaxel as first line therapy for patients with HER2-overexpressing advanced breast cancer. GEICAM/2010-04 study
Oncotarget, Vol. 8, Núm. 42, pp. 73144-73153
Contact
Legal notice
translate
en
arrow_drop_down
translate
en
arrow_drop_down
es
ca
eu
gl
fr
de